The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kubanov A.A.

State Research Center of Dermatovenerology and Cosmetology of the Ministry of Healthcare of the Russian Federation

Karamova A.E.

State Research Center of Dermatovenerology and Cosmetology of the Ministry of Healthcare of the Russian Federation

Bogdanova E.V.

State Research Center of Dermatovenerology and Cosmetology of the Ministry of Healthcare of the Russian Federation

Chikin V.V.

State Research Center of Dermatovenerology and Cosmetology of the Ministry of Healthcare of the Russian Federation

Medical and social aspects of congenital epidermolysis bullosa in the Russian Federation

Authors:

Kubanov A.A., Karamova A.E., Bogdanova E.V., Chikin V.V.

More about the authors

Read: 2335 times


To cite this article:

Kubanov AA, Karamova AE, Bogdanova EV, Chikin VV. Medical and social aspects of congenital epidermolysis bullosa in the Russian Federation. Medical Technologies. Assessment and Choice. 2021;43(2):44‑50. (In Russ.)
https://doi.org/10.17116/medtech20214302144

Recommended articles:
Features of the clinical course of multiple scle­rosis as a factor in persistent disa­bility. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):39-44
Epidemiology of inhe­rited epidermolysis bullosa in the Russian Fede­ration. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(5):574-582

References:

  1. Kubanova AA, Kubanov AA, Albanova VI, Karamova AE, Chikin VV, Rakhmatulina MR. Vrozhdennyj bulleznyj epidermoliz. Klinicheskie rekomendacii Rossijskogo obshchestva dermatovenerologov i kosmetologov. 2016. (In Russ.).
  2. Kubanov AA, Karamova AE, Chikin VV, Bogdanova EV, Monchakovskaya ES. Epidemiology and Providing of Healthcare for Patients with Inherited Epidermolysis Bullosa in the Russian Federation. Vestnik Rossiiskoi akademii medetsinskikh nauk. 2018;73(6):420-430. (In Russ.). https://doi.org/10.15690/vramn980
  3. Togo CCG, Zidorio APC, Gonçalves VSS, Hubbard L, de Carvalho KMB, Dutra ES. Quality of life in people with epidermolysis bullosa: a systematic review. Quality of Life Research. 2020;29(7):1731-1745. https://doi.org/10.1007/s11136-020-02495-5
  4. Brun J, Chiaverini C, Devos C, Leclerc-Mercier S, Mazereeuw J, Bourrat E, Maruani A, Mallet S, Abasq C, Phan A, Vabres P, Martin L, Bodemer C, Lagrange S, Lacour JP; Research Group of the French Society of Pediatric Dermatology. Pain and quality of life evaluation in patients with localized epidermolysis bullosa simplex. Orphanet Journal of Rare Diseases. 2017;12(1):119.  https://doi.org/10.1186/s13023-017-0666-5
  5. Jeon IK, On HR, Kim SC. Quality of Life and Economic Burden in Recessive Dystrophic Epidermolysis Bullosa. Annals of Dermatology. 2016;28(1):6-14.  https://doi.org/10.5021/ad.2016.28.1.6
  6. Angelis A, Kanavos P, López-Bastida J, Linertová R, Oliva-Moreno J, Serrano-Aguilar P, Posada-de-la-Paz M, Taruscio D, Schieppati A, Iskrov G, Brodszky V, von der Schulenburg JM, Chevreul K, Persson U, Fattore G; BURQOL-RD Research Network. Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe. European Journal of Health Economics. 2016;17(suppl 1):31-42.  https://doi.org/10.1007/s10198-016-0783-4
  7. Kubanov A, Karamova A, Albanova V, Smoliannikova V, Nefedova M, Chikin V, Monchakovskaya E. Allogeneic fibroblast cell therapy in the treatment of recessive dystrophic epidermolysis bullosa. Wound Medicine. 2018;21:8-11.  https://doi.org/10.1016/j.wndm.2018.04.002
  8. Kubanov AA, Karamova AE, Monchakovskaya ES. Congenital epidermolysis bullosa: modern methods of diagnosis and therapy. Prospects for regenerative medicine. Vestnik dermatologii i venerologii. 2020;96(1):10-17. (In Russ.). https://doi.org/10.25208/vdv551-2020-96-1-10-17
  9. Kubanov AA, Karamova AE, Albanova VI, Monchakovskaya ES. Therapy of patients with congenital epidermolysis bullosa using modern non-adherent wound dressings. Vestnik dermatologii i venerologii. 2019;95(1):8-11. (In Russ.). https://doi.org/10.25208/0042-4609-2019-95-1-30-40
  10. Jackson AD, Goss CH. Epidemiology of CF: How registries can be used to advance our understanding of CF population. Journal of Cystic Fibrosis. 2018;17(3):297-305.  https://doi.org/10.1016/j.jcf.2017.11.013
  11. Ivanova MA, Muhametkalieva ED, Sokolovskaya TA. Disability and medical rehabilitation in children with skin diseases in the republic of Udmurtia in 2014—2016. Klinicheskaya dermatologiya i venerologiya. 2018;17(1):5-8. (In Russ.). https://doi.org/10.17116/klinderma20181715-8
  12. Stevens LJ. Access to wound dressings for patients living with epidermolysis bullosa — an Australian perspective. International Wound Journal. 2014;11(5):505-508.  https://doi.org/10.1111/j.1742-481X.2012.01116.x
  13. Gowran RJ, Kennan A, Marshall S, Mulcahy I, Ní Mhaille S, Beasley S, Devlin M. Adopting a Sustainable Community of Practice Model when Developing a Service to Support Patients with Epidermolysis Bullosa (EB): A Stakeholder-Centered Approach. Patient. 2015;8(1):51-63.  https://doi.org/10.1007/s40271-014-0097-5

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.